Insights
Insights on health, access and innovation
Read practical thinking from Newmarket Strategy on the policy, access, reimbursement and health system issues shaping healthcare and life sciences.
HTA reflections – NICE’s interim guide for the proportionate approach to technology appraisals
NICE is implementing changes to its technology appraisal processes in what is described as a bid to increase its capacity and output, while also enabling faster patient access, and simplifying…
The Government’s £650m ‘Life Sci for Growth’ package
Today, 26 May 2023, UK Chancellor Jeremy Hunt MP brought forward a huge package of life sciences announcements, revealing a £650m war chest to fire up the Life Sciences sector. The ambitious Life…
7 Lessons for UK HealthTech Entrepreneurs
Starting a healthcare business in the UK can feel like trying to navigate a maze while juggling. It’s a challenge but it’s not impossible. With the right approach and understanding…
The Hewitt Review – what it might mean for ICSs, and for your business
In November 2022, the Secretary of State for Health and Social Care, Steve Barclay, commissioned Former Health Secretary Rt Hon Patricia Hewitt to conduct an independent review into Integrated Care…
Lessons learned from Arab Health 2023: The potential of Connected Medication Management in the UK
In January 2023, Newmarket Strategy were part of a UK delegation of health leaders who visited the global conference Arab Health in Dubai to learn more about new cutting-edge innovations that…
Medicines access just one of many things worth fighting for this Rare Disease Day
New analysis conducted by Newmarket Strategy to mark Rare Disease Day illustrates the ongoing challenge of bringing forward new treatments for people living with a rare disease. Our analysis of…
Events
